Antitrust MDL-3138 • NJ

Denosumab Patent

IN RE: Denosumab Patent Litigation

7
Pending Actions
11
Total Actions Filed
36%
Resolution Rate
Active
Status
Updated 2026-05-01

Overview

The Denosumab Patent is a federal multidistrict litigation consolidated in the District of New Jersey before Christine P. O'Hearn (U.S. District Judge). This MDL involves claims related to antitrust issues.

As of 2026-05-01, there are 7 pending actions out of 11 total actions filed, representing a 36% resolution rate.

Who May Qualify

Eligibility for this MDL typically depends on factors such as:

  • Documented exposure to or use of the product/device in question
  • Medical diagnosis of related injuries or conditions
  • Claim filed within the applicable statute of limitations

Key Information

Assigned Judge

Christine P. O'Hearn (U.S. District Judge)

District Court

District of New Jersey

MDL Number

MDL-3138

Category

Antitrust

Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.